Noninvasive detection of trophoblast protein signatures linked to early pregnancy loss using transcervical retrieval and isolation from the cervix

Thursday, July 30, 2015
Protein biomarker expression in extravillous trophoblast cells obtained noninvasively at 5–10 weeks’ gestation differs between women having a normal term pregnancy and those with an early pregnancy loss.

Read More

Trophoblast retrieval and isolation from the cervix for noninvasive prenatal screening at 5 to 20 weeks of gestation

Wednesday, June 25, 2014
Fetal cells retrieved by endocervical cytobrush at 5–20 weeks of pregnancy and isolated with immunomagnetic nanoparticles are extravillous trophoblast cells that contain intact fetal DNA useful for prenatal testing.

Read More

Has noninvasive fetal trisomy testing rung the death knell for other forms of prenatal testing

Wednesday, June 25, 2014
Obstetric vigilance for early pregnancy screening has become imperative for all pregnancies, regardless of the risk for chromosomal anomalies.

Read More

Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome

Thursday, May 24, 2012
This revised Committee Opinion outlines reproductive issues relevant towomenwith Turner syndrome, including associated maternal morbidity and mortality, oocyte donation, prenatal testing and care, and alternatives to infertility treatment, such as surrogacy or adoption.

Read More

Translate »